Skip to main content
Top
Gepubliceerd in: Quality of Life Research 10/2017

12-06-2017

Recovering from chronic myeloid leukemia: the patients’ perspective seen through the lens of narrative medicine

Auteurs: G. Graffigna, I. Cecchini, M. Breccia, E. Capochiani, R. Della Seta, S. Galimberti, A. Melosi, F. Simonetti, M. Pizzuti, S. F. Capalbo, F. Falzetti, P. Mazza, N. Di Renzo, L. Mastrullo, D. Rapezzi, E. Orlandi, T. Intermesoli, A. Iurlo, E. Pungolino, M. Pacilli

Gepubliceerd in: Quality of Life Research | Uitgave 10/2017

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

The main objective of this study is to gain a deeper understanding of how patients suffering from chronic myeloid leukemia (CML) cope with their illness. The study aims to reconstruct the subjective meaning-making process related to CML in order to gain insights into the impact the disease has on patients’ emotions and everyday lives, as well as to explore the psychological impact of their being presented with the chance to suspend their therapy and recover from the disease.

Methods

Data were gathered from a qualitative study conducted in Italy on 158 Italian CML patients. Basing the study on the narrative inquiry approach, the patients were required to describe their patient journey in a qualitative narrative diary. These contained prompts to elicit the free expression of their needs, expectations, and priorities. A lexicographic analysis was carried out with T-LAB software and in particular a thematic analysis of elementary contexts (TAECs) and a word association analysis (WAA).

Results

The TAEC detected four thematic clusters related to two factors (temporal frame and contextual setting) that explained the variance among the narratives. The WAA evidenced a wide variety of emotions, both positive and negative, as patients reacted to the possibility of interrupting their therapy.

Conclusions

A better understanding of patients’ experiences can offer insights into promoting the development of more sustainable healthcare services and into therapeutic innovation aimed at improving patients’ quality of life and at engaging them more in their treatment. The findings of this study can also help make medical professionals more aware of the patient’s burden and help them identify potential interactions and emotional levers to improve clinical relationships.
Literatuur
1.
go back to reference Sawyers, C. L., Hochhaus, A., Feldman, E., Goldman, J. M., Miller, C. B., Ottmann, O. G., et al. (2002). Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: Results of a phase II study. Blood, 99(10), 3530–3539.CrossRefPubMed Sawyers, C. L., Hochhaus, A., Feldman, E., Goldman, J. M., Miller, C. B., Ottmann, O. G., et al. (2002). Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: Results of a phase II study. Blood, 99(10), 3530–3539.CrossRefPubMed
2.
go back to reference Hanfstein, B., Müller, M. C., Hehlmann, R., Erben, P., Lauseker, M., Fabarius, A., et al. (2012). Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML). Leukemia, 26(9), 2096–2102. doi:10.1038/leu.2012.85.CrossRefPubMed Hanfstein, B., Müller, M. C., Hehlmann, R., Erben, P., Lauseker, M., Fabarius, A., et al. (2012). Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML). Leukemia, 26(9), 2096–2102. doi:10.​1038/​leu.​2012.​85.CrossRefPubMed
3.
go back to reference Steegmann, J. L., Baccarani, M., Breccia, M., Casado, L. F., García-Gutiérrez, V., Hochhaus, A., et al. (2016). European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia. Leukemia, 2016(3), 1648–1671.CrossRef Steegmann, J. L., Baccarani, M., Breccia, M., Casado, L. F., García-Gutiérrez, V., Hochhaus, A., et al. (2016). European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia. Leukemia, 2016(3), 1648–1671.CrossRef
4.
go back to reference Efficace, F., Baccarani, M., Breccia, M., Alimena, G., Rosti, G., Cottone, F., et al. (2011). Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population. Blood, 118(17), 4554–4560.CrossRefPubMed Efficace, F., Baccarani, M., Breccia, M., Alimena, G., Rosti, G., Cottone, F., et al. (2011). Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population. Blood, 118(17), 4554–4560.CrossRefPubMed
5.
go back to reference Breccia, M., & Efficace, F. (2016). Health-related quality of life outcomes in chronic myeloid leukemia patients treated with second generation tyrosine kinase inhibitors: Do we know enough? Current Medical Research and Opinion, 32(8), 1453–1454. doi:10.1080/03007995.2016.1185399.CrossRefPubMed Breccia, M., & Efficace, F. (2016). Health-related quality of life outcomes in chronic myeloid leukemia patients treated with second generation tyrosine kinase inhibitors: Do we know enough? Current Medical Research and Opinion, 32(8), 1453–1454. doi:10.​1080/​03007995.​2016.​1185399.CrossRefPubMed
7.
go back to reference Barello, S., & Graffigna, G. (2015). Engagement-sensitive decision making: Training doctors to sustain patient engagement in medical consultations. In G. Graffigna, S. Barello, & S. Triberti (Eds.), Patient engagement: A consumer-centered model to innovate healthcare (pp. 78–89). Berlin: DeGruyter Open. Barello, S., & Graffigna, G. (2015). Engagement-sensitive decision making: Training doctors to sustain patient engagement in medical consultations. In G. Graffigna, S. Barello, & S. Triberti (Eds.), Patient engagement: A consumer-centered model to innovate healthcare (pp. 78–89). Berlin: DeGruyter Open.
9.
go back to reference Street, R. L., Jr., Gordon, H. S., Ward, M. M., Krupat, E., & Kravitz, R. L. (2005). Patient participation in medical consultations: Why some patients are more involved than others. Medical Care, 43(10), 960–969.CrossRefPubMed Street, R. L., Jr., Gordon, H. S., Ward, M. M., Krupat, E., & Kravitz, R. L. (2005). Patient participation in medical consultations: Why some patients are more involved than others. Medical Care, 43(10), 960–969.CrossRefPubMed
11.
go back to reference Guilhot, F., Coombs, J., Szczudlo, T., Zernovak, O., Paolantonio, M., Christina, B., et al. (2013). The patient journey in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapies: Qualitative insights using a global ethnographic approach. The Patient: Patient-Centered Outcomes Research, 6(2), 81–92.CrossRef Guilhot, F., Coombs, J., Szczudlo, T., Zernovak, O., Paolantonio, M., Christina, B., et al. (2013). The patient journey in chronic myeloid leukemia patients on tyrosine kinase inhibitor therapies: Qualitative insights using a global ethnographic approach. The Patient: Patient-Centered Outcomes Research, 6(2), 81–92.CrossRef
12.
go back to reference Baccarani, M., Saglio, G., Goldman, J., Hochhaus, A., Simonsson, B., Appelbaum, F., et al. (2006). Evolving concepts in the management of chronic myeloid leukemia: Recommendations from an expert panel on behalf of the European LeukemiaNet. Blood, 108(6), 1809–1820.CrossRefPubMed Baccarani, M., Saglio, G., Goldman, J., Hochhaus, A., Simonsson, B., Appelbaum, F., et al. (2006). Evolving concepts in the management of chronic myeloid leukemia: Recommendations from an expert panel on behalf of the European LeukemiaNet. Blood, 108(6), 1809–1820.CrossRefPubMed
13.
go back to reference Efficace, F., Baccarani, M., Breccia, M., Cottone, F., Alimena, G., Deliliers, G. L., et al. (2013). Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib. Leukemia, 27(7), 1511–1519.CrossRefPubMed Efficace, F., Baccarani, M., Breccia, M., Cottone, F., Alimena, G., Deliliers, G. L., et al. (2013). Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib. Leukemia, 27(7), 1511–1519.CrossRefPubMed
14.
go back to reference Breccia, M., & Efficace, F. (2016). Health-related quality of life outcomes in chronic myeloid leukemia patients treated with second generation tyrosine kinase inhibitors: Do we know enough? Current Medical Research and Opinion. doi:10.1080/03007995.2016.1185399.PubMed Breccia, M., & Efficace, F. (2016). Health-related quality of life outcomes in chronic myeloid leukemia patients treated with second generation tyrosine kinase inhibitors: Do we know enough? Current Medical Research and Opinion. doi:10.​1080/​03007995.​2016.​1185399.PubMed
16.
go back to reference Rood, J. A. J., Van Zuuren, F. J., Stam, F., Van Der Ploeg, T., Huijgens, P. C., & Verdonck-de Leeuw, I. M. (2015). Cognitive coping style (monitoring and blunting) and the need for information, information satisfaction and shared decision making among patients with haematological malignancies. Psycho-Oncology, 24(5), 564–571. doi:10.1002/pon.3699.CrossRefPubMed Rood, J. A. J., Van Zuuren, F. J., Stam, F., Van Der Ploeg, T., Huijgens, P. C., & Verdonck-de Leeuw, I. M. (2015). Cognitive coping style (monitoring and blunting) and the need for information, information satisfaction and shared decision making among patients with haematological malignancies. Psycho-Oncology, 24(5), 564–571. doi:10.​1002/​pon.​3699.CrossRefPubMed
18.
go back to reference Coulter, A. (2011). Engaging patients in healthcare. New York: University Press. Coulter, A. (2011). Engaging patients in healthcare. New York: University Press.
19.
go back to reference Kleinman, A. (1978). Concepts and a model for the comparison of medical systems as cultural systems. Social Science and Medicine Part B: Medical Anthropology, 12, 85–93.CrossRef Kleinman, A. (1978). Concepts and a model for the comparison of medical systems as cultural systems. Social Science and Medicine Part B: Medical Anthropology, 12, 85–93.CrossRef
20.
go back to reference Graffigna, G., Barello, S., Riva, G., & Bosio, A. C. (2014). Patient engagement: The key to redesign the exchange between the demand and supply for healthcare in the era of active ageing. Studies in Health Technology and Informatics, 203, 85–95.PubMed Graffigna, G., Barello, S., Riva, G., & Bosio, A. C. (2014). Patient engagement: The key to redesign the exchange between the demand and supply for healthcare in the era of active ageing. Studies in Health Technology and Informatics, 203, 85–95.PubMed
22.
go back to reference Vegni, E., Zannini, L., Visioli, S., & Moja, E. A. (2001). Giving bad news: A GPs’ narrative perspective. Supportive Care in Cancer, 9(5), 390–396.CrossRefPubMed Vegni, E., Zannini, L., Visioli, S., & Moja, E. A. (2001). Giving bad news: A GPs’ narrative perspective. Supportive Care in Cancer, 9(5), 390–396.CrossRefPubMed
23.
go back to reference Charon, R. (2007). What to do with stories: The sciences of narrative medicine. Canadian Family Physician, 53(8), 1265–1267.PubMedPubMedCentral Charon, R. (2007). What to do with stories: The sciences of narrative medicine. Canadian Family Physician, 53(8), 1265–1267.PubMedPubMedCentral
27.
go back to reference Elwyn, G., Edwards, A., Kinnersley, P., & Grol, R. (2000). Shared decision making and the concept of equipoise: The competences of involving patients in healthcare choices. British Journal of General Practice, 50(460), 892–899.PubMedPubMedCentral Elwyn, G., Edwards, A., Kinnersley, P., & Grol, R. (2000). Shared decision making and the concept of equipoise: The competences of involving patients in healthcare choices. British Journal of General Practice, 50(460), 892–899.PubMedPubMedCentral
29.
go back to reference Frank, A. W. (1995). The wounded storyteller. Chicago: University of Chicago Press.CrossRef Frank, A. W. (1995). The wounded storyteller. Chicago: University of Chicago Press.CrossRef
30.
go back to reference Riley, T., & Hawe, P. (2005). Researching practice: The methodological case for narrative inquiry. Health Education Research, 20(2), 226–236.CrossRefPubMed Riley, T., & Hawe, P. (2005). Researching practice: The methodological case for narrative inquiry. Health Education Research, 20(2), 226–236.CrossRefPubMed
31.
go back to reference Muller, J. H. (1999). Narrative approaches to qualitative research in primary care. In B. F. Crabtree & W. L. Miller (Eds.), Doing qualitative research (pp. 221–238). Thousand Oaks, CA: Sage Publications. Muller, J. H. (1999). Narrative approaches to qualitative research in primary care. In B. F. Crabtree & W. L. Miller (Eds.), Doing qualitative research (pp. 221–238). Thousand Oaks, CA: Sage Publications.
32.
go back to reference Frank, A. W. (1998). Just listening: Narrative and deep illness. Families, Systems, and Health, 16(3), 197.CrossRef Frank, A. W. (1998). Just listening: Narrative and deep illness. Families, Systems, and Health, 16(3), 197.CrossRef
33.
go back to reference Mishler, E. G. (1996). Language, meaning, and narrative analysis. In Research interviewing. Context and narrative (pp. 66–116). Cambridge, MA: Harvard University Press. Mishler, E. G. (1996). Language, meaning, and narrative analysis. In Research interviewing. Context and narrative (pp. 66–116). Cambridge, MA: Harvard University Press.
34.
go back to reference Smith, C. P. (2000). Content analysis and narrative analysis. In H. T. Reis & C. M. Judd (Eds.), Handbook of research methods in social and personality psychology. Cambridge: Cambridge University Press. Smith, C. P. (2000). Content analysis and narrative analysis. In H. T. Reis & C. M. Judd (Eds.), Handbook of research methods in social and personality psychology. Cambridge: Cambridge University Press.
35.
go back to reference Bellardita, L., Graffigna, G., Donegani, S., Villani, D., Villa, S., Tresoldi, V., et al. (2012). Patient’s choice of observational strategy for early-stage prostate cancer. Neuropsychological Trends, 12(1), 107–116. Bellardita, L., Graffigna, G., Donegani, S., Villani, D., Villa, S., Tresoldi, V., et al. (2012). Patient’s choice of observational strategy for early-stage prostate cancer. Neuropsychological Trends, 12(1), 107–116.
36.
go back to reference Gambetti, R., & Graffigna, G. (2010). The concept of engagement: A systematic analysis of the ongoing debate. International Journal of Marketing Research, 52(6), 7. Gambetti, R., & Graffigna, G. (2010). The concept of engagement: A systematic analysis of the ongoing debate. International Journal of Marketing Research, 52(6), 7.
37.
go back to reference Lancia, F. (2004). Strumenti per l’analisi dei testi. Introduzione all’uso di T-LAB. Milano: Franco Angeli. Lancia, F. (2004). Strumenti per l’analisi dei testi. Introduzione all’uso di T-LAB. Milano: Franco Angeli.
38.
go back to reference Sontag, S., & Broun, H. H. (1977). Illness as metaphor (p. 343). N. Hollywood: Center for Cassette Studies. Sontag, S., & Broun, H. H. (1977). Illness as metaphor (p. 343). N. Hollywood: Center for Cassette Studies.
39.
40.
go back to reference Olsson, C., Sandin-Bojö, A. K., Bjuresäter, K., & Larsson, M. (2015). Patients treated for hematologic malignancies: Affected sexuality and health-related quality of life. Cancer Nursing, 38(2), 99–110.CrossRefPubMed Olsson, C., Sandin-Bojö, A. K., Bjuresäter, K., & Larsson, M. (2015). Patients treated for hematologic malignancies: Affected sexuality and health-related quality of life. Cancer Nursing, 38(2), 99–110.CrossRefPubMed
41.
go back to reference Cella, D., Nowinski, C. J., & Frankfurt, O. (2014). The impact of symptom burden on patient quality of life in chronic myeloid leukemia. Oncology, 87(3), 133–147.CrossRefPubMed Cella, D., Nowinski, C. J., & Frankfurt, O. (2014). The impact of symptom burden on patient quality of life in chronic myeloid leukemia. Oncology, 87(3), 133–147.CrossRefPubMed
42.
go back to reference Prochaska, J. O., & DiClemente, C. C. (1986). Toward a comprehensive model of change. New York: Springer.CrossRef Prochaska, J. O., & DiClemente, C. C. (1986). Toward a comprehensive model of change. New York: Springer.CrossRef
43.
go back to reference Prochaska, J. O., & Velicer, W. F. (1997). The transtheoretical model of health behavior change. American Journal of Health Promotion, 12(1), 38–48.CrossRefPubMed Prochaska, J. O., & Velicer, W. F. (1997). The transtheoretical model of health behavior change. American Journal of Health Promotion, 12(1), 38–48.CrossRefPubMed
44.
go back to reference Graffigna, G., Barello, S., & Triberti, S. (2015). Patient engagement: a consumer centered approach. Warsaw: De Gruyter Open. Graffigna, G., Barello, S., & Triberti, S. (2015). Patient engagement: a consumer centered approach. Warsaw: De Gruyter Open.
45.
go back to reference Kübler-Ross, E. (2009). On death and dying: What the dying have to teach doctors, nurses, clergy and their own families. New York: Scribner. Kübler-Ross, E. (2009). On death and dying: What the dying have to teach doctors, nurses, clergy and their own families. New York: Scribner.
46.
go back to reference Barello, S., & Graffigna, G. (2015). Engaging patients to recover life projectuality: An Italian cross-disease framework. Quality of Life Research, 24(5), 1087–1096.CrossRefPubMed Barello, S., & Graffigna, G. (2015). Engaging patients to recover life projectuality: An Italian cross-disease framework. Quality of Life Research, 24(5), 1087–1096.CrossRefPubMed
47.
go back to reference Andresen, R., Oades, L., & Caputi, P. (2003). The experience of recovery from schizophrenia: Towards an empirically validated stage model. Australian and New Zealand Journal of Psychiatry, 37(5), 586–594.CrossRefPubMed Andresen, R., Oades, L., & Caputi, P. (2003). The experience of recovery from schizophrenia: Towards an empirically validated stage model. Australian and New Zealand Journal of Psychiatry, 37(5), 586–594.CrossRefPubMed
48.
go back to reference Goldberg, R. J. (1983). Systematic understanding of cancer patients who refuse treatment. Psychotherapy and Psychosomatics, 39(3), 180–189.CrossRefPubMed Goldberg, R. J. (1983). Systematic understanding of cancer patients who refuse treatment. Psychotherapy and Psychosomatics, 39(3), 180–189.CrossRefPubMed
49.
go back to reference Charon, R. (2001). Narrative medicine: A model for empathy, reflection, profession, and trust. JAMA, 286(15), 1897–1902.CrossRefPubMed Charon, R. (2001). Narrative medicine: A model for empathy, reflection, profession, and trust. JAMA, 286(15), 1897–1902.CrossRefPubMed
Metagegevens
Titel
Recovering from chronic myeloid leukemia: the patients’ perspective seen through the lens of narrative medicine
Auteurs
G. Graffigna
I. Cecchini
M. Breccia
E. Capochiani
R. Della Seta
S. Galimberti
A. Melosi
F. Simonetti
M. Pizzuti
S. F. Capalbo
F. Falzetti
P. Mazza
N. Di Renzo
L. Mastrullo
D. Rapezzi
E. Orlandi
T. Intermesoli
A. Iurlo
E. Pungolino
M. Pacilli
Publicatiedatum
12-06-2017
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 10/2017
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-017-1611-8

Andere artikelen Uitgave 10/2017

Quality of Life Research 10/2017 Naar de uitgave